{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:53:01Z","timestamp":1787028781078,"version":"build-2736575974"},"reference-count":37,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Structural and Investment Funds","award":["KK.01.2.2.03.0006"],"award-info":[{"award-number":["KK.01.2.2.03.0006"]}]},{"name":"European Structural and Investment Funds","award":["KK.01.1.1.01.0006"],"award-info":[{"award-number":["KK.01.1.1.01.0006"]}]},{"name":"Scientific Centre of Excellence for Virus Immunology and Vaccines","award":["KK.01.2.2.03.0006"],"award-info":[{"award-number":["KK.01.2.2.03.0006"]}]},{"name":"Scientific Centre of Excellence for Virus Immunology and Vaccines","award":["KK.01.1.1.01.0006"],"award-info":[{"award-number":["KK.01.1.1.01.0006"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Coronavirus disease (COVID-19) exhibits a wide spectrum of clinical severity and has been associated with specific biomarkers linked to disease progression and outcomes. This retrospective study analyzed sera from 1222 adult COVID-19 patients hospitalized at the University Hospital for Infectious Diseases in Croatia. We examined the association between several laboratory biomarker levels measured at patient admission and disease severity, fatal outcomes, viral variants and clinical parameters. Deceased patients and surviving patients with severe COVID-19 exhibited significantly elevated levels of several biomarkers on admission, including hs-troponin T, N-terminal pro-brain natriuretic peptide, creatine kinase, C-reactive protein, procalcitonin, interleukin-6, lactate dehydrogenase, lactate, urea and creatinine. Random forest models identified lymphocyte percentage, D-dimers, and hs-troponin T as the most important biomarkers for fatal outcome prediction, achieving 84.1% accuracy. Patients infected with the Delta SARS-CoV-2 variant exhibited significantly higher levels of proinflammatory, cardiac and renal biomarkers. Vaccination correlated with reduced proinflammatory parameters and higher lymphocyte proportions. Hypertension, chronic renal disease and diabetes were associated with increased cardiac, renal and metabolic biomarker levels, respectively. These findings highlight the association of several laboratory biomarkers with COVID-19 severity, viral variants, vaccination status and comorbidities, potentially offering prognostic insights into COVID-19 outcomes.<\/jats:p>","DOI":"10.3390\/life15040634","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T11:26:41Z","timestamp":1744284401000},"page":"634","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic Value of Biomarkers in COVID-19: Associations with Disease Severity, Viral Variants, and Comorbidities\u2014A Retrospective Observational Single-Center Cohort Study"],"prefix":"10.3390","volume":"15","author":[{"given":"Zoran","family":"Baru\u0161i\u0107","sequence":"first","affiliation":[{"name":"University Hospital for Infectious Diseases \u201cDr. Fran Mihaljevi\u0107\u201d, 10 000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1212-3302","authenticated-orcid":false,"given":"Kristian","family":"Boduli\u0107","sequence":"additional","affiliation":[{"name":"University Hospital for Infectious Diseases \u201cDr. Fran Mihaljevi\u0107\u201d, 10 000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja","family":"Zember","sequence":"additional","affiliation":[{"name":"University Hospital for Infectious Diseases \u201cDr. Fran Mihaljevi\u0107\u201d, 10 000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"La\u0161kaj","sequence":"additional","affiliation":[{"name":"University Hospital for Infectious Diseases \u201cDr. Fran Mihaljevi\u0107\u201d, 10 000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rok","family":"\u010civljak","sequence":"additional","affiliation":[{"name":"University Hospital for Infectious Diseases \u201cDr. Fran Mihaljevi\u0107\u201d, 10 000 Zagreb, Croatia"},{"name":"School of Medicine, University of Zagreb, 10 000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Puljiz","sequence":"additional","affiliation":[{"name":"University Hospital for Infectious Diseases \u201cDr. Fran Mihaljevi\u0107\u201d, 10 000 Zagreb, Croatia"},{"name":"School of Medicine, University of Zagreb, 10 000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9536-1009","authenticated-orcid":false,"given":"Ivan-Christian","family":"Kurolt","sequence":"additional","affiliation":[{"name":"University Hospital for Infectious Diseases \u201cDr. Fran Mihaljevi\u0107\u201d, 10 000 Zagreb, Croatia"},{"name":"Faculty of Medicine, Catholic University of Croatia, 10 000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0390-2387","authenticated-orcid":false,"given":"\u017deljka Ma\u010dak","family":"\u0160afranko","sequence":"additional","affiliation":[{"name":"University Hospital for Infectious Diseases \u201cDr. Fran Mihaljevi\u0107\u201d, 10 000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidija Cvetko","family":"Krajinovi\u0107","sequence":"additional","affiliation":[{"name":"University Hospital for Infectious Diseases \u201cDr. Fran Mihaljevi\u0107\u201d, 10 000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2305-6656","authenticated-orcid":false,"given":"Petra Svoboda","family":"Kari\u0107","sequence":"additional","affiliation":[{"name":"University Hospital for Infectious Diseases \u201cDr. Fran Mihaljevi\u0107\u201d, 10 000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alemka","family":"Markoti\u0107","sequence":"additional","affiliation":[{"name":"University Hospital for Infectious Diseases \u201cDr. Fran Mihaljevi\u0107\u201d, 10 000 Zagreb, Croatia"},{"name":"Faculty of Medicine, Catholic University of Croatia, 10 000 Zagreb, Croatia"},{"name":"Faculty of Medicine, University of Rijeka, 51 000 Rijeka, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1126\/science.abn2222","article-title":"COVID-19-lessons for zoonotic disease","volume":"375","author":"Holmes","year":"2022","journal-title":"Science"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Lin, L., Liu, Y., Tang, X., and He, D. (2021). The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern. Front. Public Health, 9.","DOI":"10.3389\/fpubh.2021.775224"},{"key":"ref_4","unstructured":"Rashedi, R., Samieefar, N., Akhlaghdoust, M., Mashhadi, M., Darzi, P., and Rezaei, N. (2022). Delta Variant: The New Challenge of COVID-19 Pandemic, an Overview of Epidemiological, Clinical, and Immune Characteristics. Acta Biomed., 93."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e24402","DOI":"10.1002\/jcla.24402","article-title":"Clinical Manifestations, Treatment Options, and Comorbidities in COVID-19 Relapse Patients: A Systematic Review","volume":"36","author":"Maryam","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1080\/03007995.2022.2078081","article-title":"COVID-19 and Cardiovascular Disease: Manifestations, Pathophysiology, Vaccination, and Long-Term Implication","volume":"38","author":"Moneim","year":"2022","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Moutchia, J., Pokharel, P., Kerri, A., McGaw, K., Uchai, S., Nji, M., and Goodman, M. (2020). Clinical Laboratory Parameters Associated with Severe or Critical Novel Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis. PLoS ONE, 15.","DOI":"10.1101\/2020.04.24.20078782"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5152\/eurasianjmed.2022.22031","article-title":"The Effects of Laboratory Parameters on the Prognosis of COVID-19","volume":"54","author":"Alay","year":"2022","journal-title":"Eurasian J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.2147\/JIR.S409871","article-title":"Neutrophil\/Lymphocyte Ratio (NLR) and Lymphocyte\/Monocyte Ratio (LMR)\u2014Risk of Death Inflammatory Biomarkers in Patients with COVID-19","volume":"16","author":"Dorf","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.2146","article-title":"Predictors of COVID-19 Severity: A Literature Review","volume":"31","author":"Marin","year":"2021","journal-title":"Rev. Med. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Vilibi\u0107-\u010cavlek, T., Stevanovi\u0107, V., Brlek-Gorski, D., Feren\u010dak, I., Ferenc, T., Ujevi\u0107-Bo\u0161njak, M., Tabain, I., Janev-Holcer, N., Perkovic, I., and Anticevic, M. (2021). Emerging Trends in the Epidemiology of COVID-19: The Croatian \u2019One Health\u2019 Perspective. Viruses, 13.","DOI":"10.3390\/v13122354"},{"key":"ref_12","unstructured":"Ministry of Health of the Republic of Croatia (2025, March 16). Treatment Guidelines for Patients with Coronavirus Disease 2019 (COVID-19). Available online: https:\/\/bfm.hr\/wp-content\/uploads\/2020\/08\/Smjernice-za-lijecenje-oboljelih-od-koronavirusne-bolesti-2019-COVID-19-verzija-8-od-17.-listopada-2022.-godine.pdf."},{"key":"ref_13","unstructured":"R Core Team (2025). R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: Consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Jarczak, D., and Nierhaus, A. (2022). Cytokine Storm-Definition, Causes, and Implications. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911740"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/00325481.2022.2033563","article-title":"Therapeutic role of immunomodulators during the COVID-19 pandemic\u2014A narrative review","volume":"134","author":"Baroun","year":"2022","journal-title":"Postgrad. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s11010-021-04325-9","article-title":"Immunomodulatory agents for COVID-19 treatment: Possible mechanism of action and immunopathology features","volume":"477","author":"Rommasi","year":"2022","journal-title":"Mol. Cell. Biochem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1080\/1354750X.2020.1829056","article-title":"High sensitivity Troponin-T for prediction of adverse events in patients with COVID-19","volume":"25","author":"Singh","year":"2020","journal-title":"Biomarkers"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/ejhf.2095","article-title":"Characterization of NT-proBNP in a large cohort of COVID-19 patients","volume":"23","author":"Rey","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"ref_20","first-page":"PA650","article-title":"Association between creatine kinase level and mortality in high-risk patients with COVID-19","volume":"58","author":"Kitbalian","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1182\/blood.2021012250","article-title":"Vasculopathy in COVID-19","volume":"140","author":"Flaumenhaft","year":"2022","journal-title":"Blood"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s11239-021-02593-2","article-title":"A comprehensive review of vascular complications in COVID-19","volume":"53","author":"Acharya","year":"2022","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3748\/wjg.v29.i2.241","article-title":"Liver injury in COVID-19: Clinical features, potential mechanisms, risk factors and clinical treatments","volume":"29","author":"Zhao","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e2176","DOI":"10.1002\/rmv.2176","article-title":"Covid-19 and kidney injury: Pathophysiology and molecular mechanisms","volume":"31","author":"Ahmadian","year":"2020","journal-title":"Rev. Med. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"101602","DOI":"10.1016\/j.imu.2024.101602","article-title":"An explainable machine learning model for COVID-19 severity prognosis at hospital admission","volume":"52","author":"Tsanakas","year":"2025","journal-title":"Inform. Med. Unlocked"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40249-022-00946-4","article-title":"Comparing different machine learning techniques for predicting COVID-19 severity","volume":"11","author":"Xiong","year":"2022","journal-title":"Infect. Dis. Poverty"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.4269\/ajtmh.20-1110","article-title":"Factors of Severity in Patients with COVID-19: Cytokine\/Chemokine Concentrations, Viral Load, and Antibody Responses","volume":"103","author":"Kwon","year":"2020","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e01282023","DOI":"10.1590\/0037-8682-0128-2023","article-title":"The CXCL9\/10\/11-CXCR3 axis as a predictor of COVID-19 progression: A prospective, case-control study","volume":"56","year":"2023","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijid.2021.11.028","article-title":"Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients","volume":"115","author":"Fagyas","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s11606-022-08007-0","article-title":"The Relationship of COVID-19 Vaccination with Mortality Among 86,732 Hospitalized Patients: Subpopulations, Patient Factors, and Changes over Time","volume":"38","author":"Baker","year":"2023","journal-title":"J. Gen. Intern. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00198-023-06954-w","article-title":"Vaccination against COVID-19 reduced the mortality risk of COVID-positive hip fracture patients to baseline levels: The nationwide data-linked IMPACT Protect study","volume":"35","author":"Hall","year":"2024","journal-title":"Osteoporos. Int."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cmi.2022.12.020","article-title":"Impact of vaccination on the presence and severity of symptoms in hospitalized patients with an infection of the Omicron variant (B.1.1.529) of the SARS-CoV-2 (subvariant BA.1)","volume":"29","author":"Beraud","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"\u0110akovi\u0107 Rode, O., Boduli\u0107, K., Zember, S., Cetini\u0107 Balent, N., Novokmet, A., \u010culo, M., Ra\u0161i\u0107, \u017d., Mikuli\u0107, R., and Markoti\u0107, A. (2022). Decline of Anti-SARS-CoV-2 IgG Antibody Levels 6 Months after Complete BNT162b2 Vaccination in Healthcare Workers to Levels Observed Following the First Vaccine Dose. Vaccines, 10.","DOI":"10.3390\/vaccines10020153"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Zember, S., Boduli\u0107, K., Cetini\u0107 Balent, N., Mikuli\u0107, R., Markoti\u0107, A., and \u0110akovi\u0107 Rode, O. (2022). Slower Waning of Anti-SARS-CoV-2 IgG Levels Six Months after the Booster Dose Compared to Primary Vaccination. Vaccines, 10.","DOI":"10.3390\/vaccines10111813"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41591-022-02156-9","article-title":"Comorbidities, multimorbidity and COVID-19","volume":"29","author":"Russell","year":"2023","journal-title":"Nat. Med."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Ge, E., Li, Y., Wu, S., Candido, E., and Wei, X. (2021). Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0258154"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Turtle, L., Thorpe, M., Drake, T.M., Swets, M., Palmieri, C., Russell, C.D., Ho, A., Aston, S., Wootton, D.G., and Richter, A. (2023). Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study. PLoS Med., 20.","DOI":"10.1371\/journal.pmed.1004086"}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/4\/634\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:12:29Z","timestamp":1760029949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/15\/4\/634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["life15040634"],"URL":"https:\/\/doi.org\/10.3390\/life15040634","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]}}}